Results 31 to 40 of about 22,990 (197)

Data of PVL in Japan

, 2020
Data of patients with PVL in ...
Shunji Suzuki (7450100)
core   +1 more source

Virulence and Resistance Co-occurrence in Staphylococcus aureus: Insights from A Pediatric Cohort from Egypt

Journal of Pure and Applied Microbiology
Staphylococcus aureus (S. aureus) is a leading cause of infections in children. The emergence of multidrug-resistant (MDR) strains, especially methicillin-resistant S. aureus (MRSA), presents significant therapeutic challenges.
Rasha Hassan Hassan, Maysaa El Sayed Zaki, Eman Hosney Mohammad Salem, Lobna Abdelaziz Kassem, Dina Mohammed Abdel-Hady, Omnia A. Salem   +5 more
doaj   +1 more source

Establishment of a rat model of portal vein ligation combined with in situ splitting. [PDF]

PLoS ONE, 2014
BACKGROUND: Portal vein ligation (PVL) combined with in situ splitting (ISS) has been shown to induce remarkable liver regeneration in patients. The purpose of this study was to establish a model of PVL+ISS in rats for exploring the possible mechanisms ...
Libin Yao, Chonghui Li, Xinlan Ge, Hongdong Wang, Kesen Xu, Aiqun Zhang, Jiahong Dong   +6 more
doaj   +1 more source

Laboratory markers by PVL Case/Control Status.

, 2022
Laboratory markers by PVL Case/Control Status.
Aimee R. Kroll-Desrosiers (3636805), Ming Da Qu (12262005), Doyle V. Ward (11404497), Richard T. Ellison III (12262020), Peter G. Lazar (12262011), Carl Hollins III (12262014), Humera Kausar (12262008), Stephen Smith (117894), Bruce A. Barton (12262017)   +8 more
core   +1 more source

Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. [PDF]

PLoS Pathogens, 2010
The role of the pore-forming Staphylococcus aureus toxin Panton-Valentine leukocidin (PVL) in severe necrotizing diseases is debated due to conflicting data from epidemiological studies of community-associated methicillin-resistant S.
Bettina Löffler, Muzaffar Hussain, Matthias Grundmeier, Michaela Brück, Dirk Holzinger, Georg Varga, Johannes Roth, Barbara C Kahl, Richard A Proctor, Georg Peters   +9 more
doaj   +1 more source

Characteristics of patients with HAP or VAP due to PVL positive and PVL negative MRSA.

, 2016
Characteristics of patients with HAP or VAP due to PVL positive and PVL negative MRSA.
Jianfeng Mao (1672816), Yuanyu Guo (2818639), Limeng Shen (2818642), Xu Chu (2818645), Stijn van der Veen (124551), Chuanling Zhang (665173), Liang Guo (95092), Huali Dong (1483807)   +7 more
core   +1 more source

Clinical outcomes by PVL Case/Control Status.

, 2022
Clinical outcomes by PVL Case/Control Status.
Aimee R. Kroll-Desrosiers (3636805), Ming Da Qu (12262005), Doyle V. Ward (11404497), Richard T. Ellison III (12262020), Peter G. Lazar (12262011), Carl Hollins III (12262014), Humera Kausar (12262008), Stephen Smith (117894), Bruce A. Barton (12262017)   +8 more
core   +1 more source

Variations between initial and final PVL values.

, 2019
Variation between initial and final PVL (at the end of follow up) values in a period of least five years for IDH, IDH patients who developed HAM/TSP during follow-up and IDH/HAM/TSP patients.
Ana Paula Nunes (8150130), Janeusa Primo (8150124), Achiléa L. Bittencourt (8150133), Pedro D. Oliveira (8150121), Lourdes Farre (5661880), Everton S. Batista (8150118), Cinthya Maria Neves Varandas (8150127)   +6 more
core   +1 more source

Cerebellar Abnormalities in the Neuroimaging Spectrum of CLTC‐Related Disorder

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Pathogenic variants in CLTC, which encodes the clathrin heavy chain involved in vesicle‐mediated trafficking in neurons, cause a rare neurodevelopmental disorder associated with variable severity of global developmental delay and intellectual disability and structural brain abnormalities. Although corpus callosum and white matter anomalies are
Daniel Charouf, Andrea Accogli, Fadi F. Hamdan, Francesca Nardecchia, Toshiyuki Itai, Kenneth A. Myers, Christine Saint Martin, Myriam Srour   +7 more
wiley   +1 more source

Patient demographics by PVL′ Case/Control status.

, 2022
Patient demographics by PVL′ Case/Control status.
Aimee R. Kroll-Desrosiers (3636805), Ming Da Qu (12262005), Doyle V. Ward (11404497), Richard T. Ellison III (12262020), Peter G. Lazar (12262011), Carl Hollins III (12262014), Humera Kausar (12262008), Stephen Smith (117894), Bruce A. Barton (12262017)   +8 more
core   +1 more source